Iddo Nadav Weiner

ConvergeCELL: An end-to-end platform from patient transcriptomics to therapeutic hypotheses

ConvergeCELL translates patient transcriptomics into therapeutic hypotheses by integrating patient representation, interpretability, and large language models, outperforming baselines in gene recovery and classification.

Zero-Shot Design of a Biobetter Cetuximab: Enhanced EGFR Affinity with Preserved Developability

The paper designs a biobetter version of cetuximab with enhanced EGFR affinity using ConvergeAB, showing improved binding without compromising developability.